Global Clinical Trials for Alzheimer's Disease is a handy one-stop reference for researchers
and physicians planning and conducting global clinical trials in this area. This book addresses
important considerations that may arise during the successful design and execution of these
trials including site selection local regulatory issues pharmacogenomics ethical matters
and much more. Given the saturation of traditional clinical trial markets and the worldwide
progression of Alzheimer's disease there is a need to focus on clinical trials in emerging
markets and developing countries. This book provides you with a practical approach to
recognizing the opportunities and tackling the challenges that are present during the planning
and execution of global clinical trials for Alzheimer's disease.
